ID   PPMI.I.1079.1.ISO.3
AC   CVCL_F4XA
SY   Iso-WT 41568 LRRK2+ p.R1441G ISO.3
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_corrected; p.Arg1441Gly (c.4321C>G); ClinVar=VCV000001936; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PPMI).
CC   Omics: Genomics; Whole genome sequencing.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5S8 ! PPMI.I.1079.1
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-06-26; Last updated: 25-06-26; Version: 1
//